Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma.

Swaidani S, Cheng G, Lauer ME, Sharma M, Mikecz K, Hascall VC, Aronica MA.

J Biol Chem. 2013 Jan 4;288(1):412-22. doi: 10.1074/jbc.M112.389874. Epub 2012 Nov 1.

2.

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M.

J Exp Med. 1995 Nov 1;182(5):1527-36.

3.

Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.

Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY.

Eur J Pharmacol. 2006 Oct 10;547(1-3):125-35. Epub 2006 Jul 13.

PMID:
16956605
4.

Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma.

Hofstra CL, Van Ark I, Savelkoul HF, Cruikshank WW, Nijkamp FP, Van Oosterhout AJ.

Clin Exp Allergy. 1998 Dec;28(12):1571-80.

PMID:
10024230
5.

A crucial role of sialidase Neu1 in hyaluronan receptor function of CD44 in T helper type 2-mediated airway inflammation of murine acute asthmatic model.

Katoh S, Maeda S, Fukuoka H, Wada T, Moriya S, Mori A, Yamaguchi K, Senda S, Miyagi T.

Clin Exp Immunol. 2010 Aug;161(2):233-41. doi: 10.1111/j.1365-2249.2010.04165.x. Epub 2010 May 10.

6.

Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma.

Cheng G, Swaidani S, Sharma M, Lauer ME, Hascall VC, Aronica MA.

Matrix Biol. 2011 Mar;30(2):126-34. doi: 10.1016/j.matbio.2010.12.003. Epub 2011 Jan 18.

7.
8.

Tumor necrosis factor-stimulated gene-6 (TSG-6) amplifies hyaluronan synthesis by airway smooth muscle cells.

Lauer ME, Cheng G, Swaidani S, Aronica MA, Weigel PH, Hascall VC.

J Biol Chem. 2013 Jan 4;288(1):423-31. doi: 10.1074/jbc.M112.389882. Epub 2012 Nov 5.

9.

Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma.

Zhu L, Zhuo L, Kimata K, Yamaguchi E, Watanabe H, Aronica MA, Hascall VC, Baba K.

Int Arch Allergy Immunol. 2010;153(3):223-33. doi: 10.1159/000314362. Epub 2010 May 18.

10.

Hyaluronan Rafts on Airway Epithelial Cells.

Abbadi A, Lauer M, Swaidani S, Wang A, Hascall V.

J Biol Chem. 2016 Jan 15;291(3):1448-55. doi: 10.1074/jbc.M115.704288. Epub 2015 Nov 24.

11.

CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma.

Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, Cattamanchi A, Weinstock J, Elliott D, Sperling AI, Bluestone JA.

Am J Respir Cell Mol Biol. 1998 Apr;18(4):453-62.

PMID:
9533932
12.

IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma.

Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD.

J Immunol. 2002 May 15;168(10):5278-86.

13.

Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation.

Wang J, Homer RJ, Chen Q, Elias JA.

J Immunol. 2000 Oct 1;165(7):4051-61.

14.

Increased Th2 cytokine secretion, eosinophilic airway inflammation, and airway hyperresponsiveness in neurturin-deficient mice.

Michel T, Thérésine M, Poli A, Domingues O, Ammerlaan W, Brons NH, Hentges F, Zimmer J.

J Immunol. 2011 Jun 1;186(11):6497-504. doi: 10.4049/jimmunol.1001673. Epub 2011 Apr 20.

15.

Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation.

Lauer ME, Majors AK, Comhair S, Ruple LM, Matuska B, Subramanian A, Farver C, Dworski R, Grandon D, Laskowski D, Dweik RA, Erzurum SC, Hascall VC, Aronica MA.

J Biol Chem. 2015 Sep 18;290(38):23124-34. doi: 10.1074/jbc.M115.663823. Epub 2015 Jul 24.

17.

Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.

Baelder R, Fuchs B, Bautsch W, Zwirner J, Köhl J, Hoymann HG, Glaab T, Erpenbeck V, Krug N, Braun A.

J Immunol. 2005 Jan 15;174(2):783-9.

18.

Allergic lung inflammation is mediated by soluble tumor necrosis factor (TNF) and attenuated by dominant-negative TNF biologics.

Maillet I, Schnyder-Candrian S, Couillin I, Quesniaux VF, Erard F, Moser R, Fleury S, Kanda A, Dombrowicz D, Szymkowski DE, Ryffel B.

Am J Respir Cell Mol Biol. 2011 Oct;45(4):731-9. doi: 10.1165/rcmb.2010-0512OC. Epub 2011 Feb 4.

PMID:
21297077
19.
20.

Supplemental Content

Support Center